Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Granger

Showing results (561-570 of 1,253) with videos related to

Pageof 126
Sort By:
European Heart Journal|September 28, 2020
Angiotensin-converting enzyme 2 (ACE2) levels in relation to risk factors for COVID-19 in two large cohorts of patients with atrial fibrillationLars Wallentin, Johan Lindbäck, Niclas Eriksson, et al.
European Heart Journal|October 17, 2006
The impact of anthropomorphic indices on clinical outcomes in patients with acute ST-elevation myocardial infarctionRajendra H Mehta, Robert M Califf, Jyotsna Garg, et al.
JAMA|February 12, 1998
Prognostic significance of the initial electrocardiogram in patients with acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA for Occluded Coronary ArteriesW R Hathaway, E D Peterson, G S Wagner, et al.
Journal of the American College of Cardiology|March 29, 2023
Early Lead Extraction for Infected Implanted Cardiac Electronic Devices: JACC Review Topic of the WeekDhanunjaya R Lakkireddy, Douglas S Segar, Ami Sood, et al.
The American Journal of Medicine|May 30, 2002
The failure of orally administered glycoprotein IIb/IIIa inhibitors to prevent recurrent cardiac eventsL Kristin Newby, Robert M Califf, Harvey D White, et al.
Circulation|April 1, 1995
Rebound increase in thrombin generation and activity after cessation of intravenous heparin in patients with acute coronary syndromesC B Granger, J M Miller, E G Bovill, et al.
American Heart Journal|December 13, 2005
Design and rationale of the MICHELANGELO Organization to Assess Strategies in Acute Ischemic Syndromes (OASIS)-5 trial program evaluating fondaparinux, a synthetic factor Xa inhibitor, in patients with non-ST-segment elevation acute coronary syndromes, Shamir R Mehta, Salim Yusuf, et al.
Archives of Internal Medicine|March 30, 2011
Age and outcomes in ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: findings from the APEX-AMI trialS Michael Gharacholou, Renato D Lopes, Karen P Alexander, et al.
The American Journal of Cardiology|March 12, 1999
Correlation of angiographic findings and right (V1 to V3) versus left (V4 to V6) precordial ST-segment depression in inferior wall acute myocardial infarctionY Birnbaum, G S Wagner, G I Barbash, et al.
The American Journal of Cardiology|July 7, 2009
Contribution of bleeding and thromboembolic events to in-hospital mortality among patients with thrombocytopenia treated with heparinE Marc Jolicoeur, E Magnus Ohman, Emily Honeycutt, et al.
Pageof 126

Showing results (561-570 of 1,253) with videos related to

Sort By:
Pageof 126
European Heart Journal|September 28, 2020
Angiotensin-converting enzyme 2 (ACE2) levels in relation to risk factors for COVID-19 in two large cohorts of patients with atrial fibrillationLars Wallentin, Johan Lindbäck, Niclas Eriksson, et al.
European Heart Journal|October 17, 2006
The impact of anthropomorphic indices on clinical outcomes in patients with acute ST-elevation myocardial infarctionRajendra H Mehta, Robert M Califf, Jyotsna Garg, et al.
JAMA|February 12, 1998
Prognostic significance of the initial electrocardiogram in patients with acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA for Occluded Coronary ArteriesW R Hathaway, E D Peterson, G S Wagner, et al.
Journal of the American College of Cardiology|March 29, 2023
Early Lead Extraction for Infected Implanted Cardiac Electronic Devices: JACC Review Topic of the WeekDhanunjaya R Lakkireddy, Douglas S Segar, Ami Sood, et al.
The American Journal of Medicine|May 30, 2002
The failure of orally administered glycoprotein IIb/IIIa inhibitors to prevent recurrent cardiac eventsL Kristin Newby, Robert M Califf, Harvey D White, et al.
Circulation|April 1, 1995
Rebound increase in thrombin generation and activity after cessation of intravenous heparin in patients with acute coronary syndromesC B Granger, J M Miller, E G Bovill, et al.
American Heart Journal|December 13, 2005
Design and rationale of the MICHELANGELO Organization to Assess Strategies in Acute Ischemic Syndromes (OASIS)-5 trial program evaluating fondaparinux, a synthetic factor Xa inhibitor, in patients with non-ST-segment elevation acute coronary syndromes, Shamir R Mehta, Salim Yusuf, et al.
Archives of Internal Medicine|March 30, 2011
Age and outcomes in ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: findings from the APEX-AMI trialS Michael Gharacholou, Renato D Lopes, Karen P Alexander, et al.
The American Journal of Cardiology|March 12, 1999
Correlation of angiographic findings and right (V1 to V3) versus left (V4 to V6) precordial ST-segment depression in inferior wall acute myocardial infarctionY Birnbaum, G S Wagner, G I Barbash, et al.
The American Journal of Cardiology|July 7, 2009
Contribution of bleeding and thromboembolic events to in-hospital mortality among patients with thrombocytopenia treated with heparinE Marc Jolicoeur, E Magnus Ohman, Emily Honeycutt, et al.
Pageof 126